Renin Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Materials

Industry

Estimated Revenue & Valuation

  • Renin's estimated annual revenue is currently $72M per year.(i)
  • Renin's estimated revenue per employee is $353,100

Employee Data

  • Renin has 204 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$38.5M1209%N/AN/A
#2
$50.5M1436%N/AN/A
#3
$31.5M983%N/AN/A
#4
$50.8M1447%N/AN/A
#5
$190.6M475N/AN/AN/A
#6
$68.1M193-2%N/AN/A
#7
$44.6M1397%N/AN/A
#8
$62.5M177-6%N/AN/A
#9
$57.9M1644%N/AN/A
#10
$26.6M83-16%N/AN/A
Add Company

Renin is an international manufacturer and distributor for a wide range of indoor barn, bifold, and bypass doors. With innovative solutions and the highest quality products, Renin not only manufacturers and distributes doors, but also carries hardware, room dividers, fabricated glass, and home décor elements for both residential and commercial spaces. With our commitment to quality and our innovative approach to leadership, we have been able to create unique solutions to solve every customer’s needs. We were the inventor of the sliding mirror closet door over 50 years ago. With over half a century of experience under our belts, we are a company that you can trust and depend on. Renin was awarded Best of Houzz 2016: http://bit.ly/2diDZKD

keywords:N/A

N/A

Total Funding

204

Number of Employees

$72M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Renin News

2022-04-20 - Direct Renin Inhibitors Dris Market Size And Forecast | Noden ...

Direct Renin Inhibitors Dris Market Size And Forecast | Noden Pharma, LGM Pharma, Cayman, Vitae-GSK, Daiichi Sankyo, Novartis, Merck-Frost,...

2022-03-30 - Renin-Angiotensin Blockade Reduces Readmission for Acute ...

Figures etc. Original article. peer-reviewed. Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell...

2022-03-22 - Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes. Download PDF Copy. Shanet Susan...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$68.4M204N/AN/A
#2
N/A20417%N/A
#3
$74.8M2065%N/A
#4
$63.9M2159%N/A
#5
N/A22890%N/A